Cite
MLA Citation
R Popat et al.. “P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?.” HemaSphere, vol. 6, n.d., p. 18. http://access.bl.uk/ark:/81055/vdc_100153435583.0x00001b